Editorial · 13 Mar 2019
Short communicationPublished 6 Feb 2017
The Growth/Differentiation Factor-15 in Chronic Heart Failure: New Challenge in Biomarker-Guided Therapy?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Heart failure (HF) biomarker-guided therapy is promising method, which directs to improving of clinical status, attenuation of admission/readmission to the hospital and reduces of mortality rate. Many biological markers, i.e. inflammatory cytokines, are under consideration as a surrogate target for HF treatment, while there is known biomarkers with established predictive value, such as natriuretic peptides. However, discovery of new biomarkers reflecting various underlying mechanisms of HF and appearing to be surrogate targets for biomarkerguided therapy is promising. Nowadays, growth differentiation factor 15 (GDF-15) is suggested a target biomarker for HF treatment. Although elevated level of GDF-15 associated with HF development, progression, and prognosis, there is not represented evidence regarding direct comparison of this biomarker with other clinical risk predictors and biomarkers. Moreover, GDF-15 might serve as a contributor to endothelial progenitor cells (EPC) dysfunction by inducing EPC death/autophagy and limiting their response to angiopoetic and reparative effects. The short communication is discussed whether GDF-15 is good molecular target for HF guided therapy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 18 Sep 2018
Heart Congress 2017-Future Strategies for Managing Congestion in Heart Failure Patients Using Cardiac Biomarker-Guided Self-Testing- Joseph T. Smith- Biodesign Institute at Arizona State University, USA
Short communication · 2017
Future Strategies for Managing Congestion in Heart Failure Patients Using Cardiac Biomarker-Guided Self-Testing
Editorial · 19 Mar 2019
Cardiology 2018 : Future Strategies for Managing Congestion in Heart Failure Patients Using Cardiac Biomarker-Guided Self-Testing - Joseph T. Smith - Arizona State University
Short communication · 2017
Growth-Differentiation Factor-15 as Additional Prognostic Biomarkers in Heart Failure
More from this journal
The newest in Translational Biomedicine.
Research article · 30 Dec 2024
An Examination of the Correlation between Advancements in TBI Research and the Long-Term Health Outcomes of High-Risk Populations: The Use of Biomarkers vs. Symptom Assessment
Perspective · 20 Dec 2024
Preclinical and Animal Studies in Translational Biomedicine: Bridging the Gap Between Bench and Bedside
Perspective · 20 Dec 2024
Regenerative Medicine in Translational Biomedicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Biomedicine
- SubjectCardiology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Alexander E Berezin”

